A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1.
You may not be if
prior exposure to agents directed at the HER axis;
prior chemotherapy or systemic anti-tumor therapy after advanced disease;
unstable systemic disease;
any other malignancy within last 5 years, except cured basal cell cancer of skin or cured cancer in situ of cervix;
brain metastasis or spinal cord compression.
Clareo Health | A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
